Received Mar 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | 1967338 | — |
No adverse effects reported.; HCP reports patient received expired dose of GARDASIL 9 on 2/4/2026.; This spontaneous report was received from a nurse and refers to a 12-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies, or concomitant therapies was provided. On 04-Feb-2026, the patient was vaccinated with an expired dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (dose, route of administration and anatomical location were not reported, lot number 1967338, which was verified to be valid, expiration date established on 26-Jan-2026) for prophylaxis (Expired product administered). No adverse effects reported.